Articles By Philip Robinson, MBChB, PhD, FRACP
IL-17 Inhibitors In Non-Radiographic Axial SpA
This meeting sees new data on using anti-IL-17 agents in non-radiographic axial SpA. Up until now these patients have only had TNF inhibitors available, so data about the efficacy of IL17 inhibitors is really important.
Read Article
Tapering Of Therapy In RA: Maybe Not So Aggressive Next Time
This ACR has seen some more great work on tapering of therapy in rheumatoid arthritis. It’s a hot topic and one which I get asked about all the time by my patients.
Read Article
Update on Osteoporosis
This session was an update on the management of osteoporosis given by Professor Christian Roux from France.
Read Article
Biosimilar Data at #EULAR2018
Biosimilars are here, and more are being registered all the time, so I was really interested in the biosimilar data at the meeting.
Read Article
Cardiovascular Events: Allopurinol vs. Febuxostat
In the registration trials for febuxostat there were concerns about a cardiovascular (CV) safety signal. In studies of the effect of allopurinol on CV risk/events allopurinol has found to be protective so whether febuxostat is different is a point to clarify.
Read Article
Large Vessel Vasculitis: Giant Cell Arteritis and Takayasu Arteritis
Prof Weyland started by explaining that giant cell arteritis (GCA) and Takayasu Arteritis (TA) are granulomatous forms of arteritis.
Read Article
The Red Eye in the Rheumatology Patient
Professor Rosenbaum is well known for his expertise in rheumatic eye disease and he gave a great summary of how to approach your patient having a red eye.
Read Article
Reactive Arthritis
Prof Robert Inman gave a great summary of the state of the art in reactive arthritis (ReA).
Read Article